Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Chesler

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Oncotarget|January 12, 2023
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Blood|June 24, 2020
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activityLivingstone Fultang, Sarah Booth, Orli Yogev, et al.
JHEP Reports : Innovation in Hepatology|May 21, 2026
IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancersGiulia Tesini, Jack Greaves, Olivia Knight, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Oncotarget|July 21, 2016
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsLynsey Vaughan, Paul A Clarke, Karen Barker, et al.
Radiology|November 22, 2012
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaYann Jamin, Elizabeth R Tucker, Evon Poon, et al.
Developmental Cell|September 21, 2023
Palbociclib releases the latent differentiation capacity of neuroblastoma cellsKirsty M Ferguson, Sarah L Gillen, Lewis Chaytor, et al.
Cancer Research|October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance ElastographyJin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Cell Reports|December 21, 2017
Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell CycleGabriele Büchel, Anne Carstensen, Ka-Yan Mak, et al.
Cancer Research|May 20, 2016
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting RadioresistanceOrli Yogev, Karen Barker, Arti Sikka, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Oncotarget|January 12, 2023
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Blood|June 24, 2020
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activityLivingstone Fultang, Sarah Booth, Orli Yogev, et al.
JHEP Reports : Innovation in Hepatology|May 21, 2026
IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancersGiulia Tesini, Jack Greaves, Olivia Knight, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Oncotarget|July 21, 2016
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsLynsey Vaughan, Paul A Clarke, Karen Barker, et al.
Radiology|November 22, 2012
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaYann Jamin, Elizabeth R Tucker, Evon Poon, et al.
Developmental Cell|September 21, 2023
Palbociclib releases the latent differentiation capacity of neuroblastoma cellsKirsty M Ferguson, Sarah L Gillen, Lewis Chaytor, et al.
Cancer Research|October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance ElastographyJin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Cell Reports|December 21, 2017
Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell CycleGabriele Büchel, Anne Carstensen, Ka-Yan Mak, et al.
Cancer Research|May 20, 2016
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting RadioresistanceOrli Yogev, Karen Barker, Arti Sikka, et al.
Pageof 12